Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06129123 · ClinicalTrials.gov registry record · NA

An Online Intervention to Reduce E-cigarette Use and Susceptibility to Smoking in Young Adults

A NA study of E-cigarette Use, sponsored by University of Southern California.

Recruiting
Registry status
NA
Development phase
100
Enrollment target
1
Study location

NCT06129123: Recruiting NA study of E-cigarette Use, sponsored by University of Southern California.

NCT06129123 is a NA study of E-cigarette Use that is actively recruiting participants, run by University of Southern California. The registered enrollment target is 100 participants, below the 196-participant average among 12 other E-cigarette Use trials with a reported enrollment target (49% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06129123, a NA study of E-cigarette Use, is actively recruiting participants, sponsored by University of Southern California.

RECRUITING
Registry status
NA
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

The goal of this intervention development and pilot clinical trial is to determine whether receiving the brief online intervention results in greater reductions in past 7-day e-cigarette use frequency and smoking susceptibility over an 8-week period compared to receiving the control condition in young adults who currently use e-cigarettes. Participants in the experimental condition will be asked to complete the 30-minute mobile-based program. Participants in the assessment-only control will be given the option to access the intervention after they complete their final survey at 8 weeks. All participants will complete our online surveys at baseline as well as 2-weeks, 4-weeks, and 8-weeks post-randomization. Researchers will compare outcomes among the intervention and control groups to determine the efficacy of the intervention.

Primary Outcome

Participants will report the number of (1) days they vaped, (2) times they picked up their device to vape per day, and (3) puffs they took before putting their vaping device away per day in the past 7 days and 30 days

Conditions Studied

Interventions

  • BEHAVIORAL Live Free From E-cigarettes

Study Locations (1)

California

  • University of Southern California - Los Angeles

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2025-07-01
Est. Completion 2026-01-23
Phase NA
University of Southern California

617 total trials

What NCT06129123 shows while recruiting

NCT06129123 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 196-participant average among 12 other E-cigarette Use trials with a reported enrollment target (49% lower).

The record links to 1 condition, with E-cigarette Use appearing as the primary indexed condition, and to 1 intervention - of which Live Free From E-cigarettes is the first listed.

NCT06129123 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT06129123 about?

NCT06129123 is a clinical study titled "An Online Intervention to Reduce E-cigarette Use and Susceptibility to Smoking in Young Adults". The goal of this intervention development and pilot clinical trial is to determine whether receiving the brief online intervention results in greater reductions in past 7-day e-cigarette use frequency and smoking susceptibility over an 8-week period compared to receiving the control condition in you...

What is the current status of trial NCT06129123?

This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2025-07-01. Estimated completion is 2026-01-23.

What conditions does trial NCT06129123 study?

This clinical trial studies the following conditions: E-cigarette Use.

What interventions are being tested in trial NCT06129123?

The interventions under investigation include: Live Free From E-cigarettes (BEHAVIORAL).

Who is sponsoring clinical trial NCT06129123?

This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06129123 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for E-cigarette Use

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06129123's enrollment target sits among peer trials

100 6th of 12 higher than 7 of 12 other E-cigarette Use trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other E-cigarette Use trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06129123, the US trial registry maintained by the National Library of Medicine. NCT06129123 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.